Short-term GnRH- Antagonist Treatment to Lower LH Pulsatility in Women With PCOS Aiming to Improve Hormonal Functions - SOPKGANI

2024-514102-32-00 Protocol 2022_0016 Human pharmacology (Phase I) - First administration to humans Ended

Start 17 Apr 2024 · End 9 Feb 2025 · Status Ended · 1 EU/EEA countries · 1 sites · Protocol 2022_0016

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ended
Participants planned 20
Countries 1
Sites 1

Polycystic ovarian

Key facts

Sponsor
Centre Hospitalier Universitaire De Lille
Participant type
Patients
Age range
18-64 years
Gender
Female
Therapeutic area
Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
Trial duration
17 Apr 2024 → 9 Feb 2025
Decision date (initial)
2024-11-08
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2024-514102-32-00
EudraCT number
2023-000176-35
ClinicalTrials.gov
NCT05751252

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Polycystic ovarian

VersionLevelCodeTermSystem organ class
27.0 PT 10065161 Polycystic ovarian syndrome 10038604

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Centre Hospitalier Universitaire De Lille

Sponsor organisation
Centre Hospitalier Universitaire De Lille
Address
2 Avenue Oscar Lambret, Cs 70001 Cs 70001
City
Lille Cedex
Postcode
59037
Country
France

Scientific contact point

Organisation
Centre Hospitalier Universitaire De Lille
Contact name
Pr Sophie CATTEAU JONARD

Public contact point

Organisation
Centre Hospitalier Universitaire De Lille
Contact name
Mrs. Brigitte COURTOIS

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ended 20 1
Rest of world 0

Investigational sites

France

1 site · Ended
Centre Hospitalier Universitaire De Lille
Service de Gynécologie Médicale, Avenue Eugene Avinee, 59037, Lille Cedex

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2024-04-17 2025-02-09 2024-04-17 2025-02-09

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-09-27 France Acceptable
2024-11-08
2024-11-08